Biolase and EdgeEndo have teamed up to develop EdgePRO, a next-generation laser-assisted microfluidic irrigation device for endodontists. It will be designed to offer a solution for endodontists seeking more from their current cleaning and disinfection techniques such as sodium hypochlorite, ethylenediaminetetraacetic acid, chlorhexidine, or two-in-one or three-in-one irrigation solutions, the companies said.
Biolase expects to submit a premarket notification (510(k)) to the US Food and Drug Administration for the co-developed device in the second quarter of 2021. It is not yet available for sale in the United States.
The EdgePRO will build upon Biolase’s patented and proven platform, the companies said, which has been shown to significantly improve debridement, cleaning, and disinfection up to 99% and removes smear layer and biofilms using the most advanced laser light sound technology with traditional irrigation solutions.
“We had been researching advanced microfluidic irrigation technologies in the high-tech endodontic irrigation market for several years and concluded that Biolase would be an ideal business partner for EdgeEndo,” said Charles Goodis, DDS, EdgeEndo founder and CEO.
“Their proprietary Waterlase Er,Cr:YSGG technology has proven to be clinically effective in endodontics over the last 20 years. This is reinforced by the publication of more than 75 research papers and the technology’s use by thousands of dentists around the world to enhance clinical outcomes,” Goodis said.
“Partnering with Biolase will provide us with access to an endodontic-specific, minimally invasive technology with proprietary and patented radial firing tip technology to incorporate into our EdgePRO product,” said Goodis.
“We are excited about this collaboration and in the near term look forward to developing a technology for endodontists that has the potential to improve patient experiences and clinical outcomes,” Goodis said.
“We are very pleased with the efforts thus far on the design and performance of the EdgePRO as our first OEM laser product,” said Biolase president and CEO John Beaver.
“Approximately 75% of all endodontists routinely use EdgeEndo endodontic files, burs, and bioceramics, providing reach and relationships with the endodontists that will further our goal of making Waterlase technology the standard of care in endodontics,” said Beaver.
Related Articles
Endodontics Residents to Be Trained on Waterlase Dental Lasers
Superior Outcomes and the Biolase Repair Perio Laser Protocol
File Assortment Promises Flexibility and Durability
